Bas Van Rhijn
Overview
Explore the profile of Bas Van Rhijn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
309
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Kwast T, Van Rhijn B, Kamat A, Cheng L
Eur Urol Focus
. 2021 May;
8(3):885-886.
PMID: 33992577
No abstract available.
2.
Mostafid H, Babjuk M, Bochner B, Lerner S, Witjes F, Palou J, et al.
Eur Urol
. 2020 Mar;
77(6):669-670.
PMID: 32192815
Transurethral resection of bladder tumour is the initial, most critical step in the management of bladder cancer; as such, this is a call to arms for the urological community to...
3.
Jubber I, Shariat S, Conroy S, Tan W, Gordon P, Lotan Y, et al.
Eur Urol
. 2019 Dec;
77(5):583-598.
PMID: 31791622
Context: Non-visible haematuria (NVH) is a common finding and may indicate undiagnosed urological cancer. The optimal investigation of NVH is unclear, given the incidence of cancer and the public health...
4.
van de Kamp M, Meijer R, Pos F, Kerst M, van Werkhoven E, Van Rhijn B, et al.
Urol Oncol
. 2018 Mar;
36(6):307.e1-307.e8.
PMID: 29580697
Introduction: Small cell carcinoma of the bladder (SCCB) is a rare and lethal disease. Previously, we and others have reported a bladder sparing strategy with platinum-etoposide-based chemotherapy followed by radiotherapy...
5.
Necchi A, Mariani L, Lo Vullo S, Yu E, Woods M, Wong Y, et al.
Eur Urol Focus
. 2017 Jul;
5(2):242-249.
PMID: 28753897
Background: Limited data is available on the role, and extent of, postchemotherapy lymphadenectomy (PC-LND) in patients with clinical evidence of pelvic (cN1-3) or retroperitoneal (RP) lymph node spread from urothelial...
6.
Grivas N, Wit E, Pos F, De Jong J, Vegt E, Bex A, et al.
Int J Radiat Oncol Biol Phys
. 2017 Jan;
97(2):347-354.
PMID: 28068243
Purpose: To assess the efficacy of robotic-assisted laparoscopic sentinel lymph node (SLN) dissection (SLND) to select those patients with prostate cancer (PCa) who would benefit from additional pelvic external beam...
7.
Babjuk M, Burger M, Comperat E, Palou J, Roupret M, Van Rhijn B, et al.
Eur Urol
. 2016 Dec;
71(6):e173-e174.
PMID: 27939074
No abstract available.
8.
Bostrom P, Mirtti T, Van Rhijn B, Fleshner N, Finelli A, Laato M, et al.
Bladder Cancer
. 2016 Jul;
2(2):263-272.
PMID: 27376145
Benefits of adjuvant chemotherapy (AC) and extent of pelvic lymph node dissection (PLND) in radical cystectomy (RC) are debated. Results from randomized trials are still expected. To analyze the effects...
9.
Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, et al.
BJU Int
. 2015 Oct;
118(1):44-52.
PMID: 26469362
Objectives: To determine if a re-transurethral resection (TUR), in the presence or absence of muscle at the first TUR in patients with T1-high grade (HG)/Grade 3 (G3) bladder cancer, makes...
10.
Kamat A, Vlahou A, Taylor J, Hudson M, Pesch B, Ingersoll M, et al.
Urol Oncol
. 2014 Oct;
32(7):1069-77.
PMID: 25306288
Objective: Diagnosis and surveillance of high risk non muscle-invasive bladder cancer (NMIBC) represent specific challenges to urologists. In contrast to low/intermediate risk tumors, these tumors recur more frequently. A significant...